+1 (202) 780-3397
2021: Volume 4, Issue 5
Abstract P.1-1
The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases
Author(s): Viviana Falcón Cama
Abstract P.1-0
Eosinophilia during natalizumab treatment: Incidence, risk factors, and temporal patterns
Author(s): Milad-Kazava Keshvari
Abstract P.1-2
Asymmetric Ensemble of Asymmetric U-Net Models for Brain Tumor Segmentation With Uncertainty Estimation
Author(s): Sarahi Rosas González
Abstract P.1-1
Quantitative Imaging of Blood-Brain Barrier Permeability Following Repetitive Mild Head Impacts
Author(s): Joshua Leaston
Short Communication P.0-1
P140 peptide, a new immunomodulation tool for lupus may have applications in other chronic inflammatory conditions
Author(s): Sylviane Muller
Short Communication P.0-1
Dapirolizumab pegol A new treatment of cases with SLE by inhibiting CD40L
Author(s): Farnaz Fallah-Arani